- Home
- GXAI vs FLGC Comparison
GXAI vs FLGC Comparison
Compare GXAI & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- FLGC
- Stock Information
- Founded
- GXAI 2021
- FLGC 2019
- Country
- GXAI United States
- FLGC United States
- Employees
- GXAI N/A
- FLGC N/A
- Industry
- GXAI
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- GXAI
- FLGC Health Care
- Exchange
- GXAI Nasdaq
- FLGC Nasdaq
- Market Cap
- GXAI 13.0M
- FLGC 13.5M
- IPO Year
- GXAI 2023
- FLGC 2021
- Fundamental
- Price
- GXAI $1.36
- FLGC $8.01
- Analyst Decision
- GXAI
- FLGC Strong Buy
- Analyst Count
- GXAI 0
- FLGC 1
- Target Price
- GXAI N/A
- FLGC $156.00
- AVG Volume (30 Days)
- GXAI 197.6K
- FLGC 26.6K
- Earning Date
- GXAI 11-14-2025
- FLGC 11-05-2025
- Dividend Yield
- GXAI N/A
- FLGC N/A
- EPS Growth
- GXAI N/A
- FLGC N/A
- EPS
- GXAI N/A
- FLGC N/A
- Revenue
- GXAI $198,711.00
- FLGC $39,649,000.00
- Revenue This Year
- GXAI N/A
- FLGC N/A
- Revenue Next Year
- GXAI N/A
- FLGC $10.48
- P/E Ratio
- GXAI N/A
- FLGC N/A
- Revenue Growth
- GXAI 72158.55
- FLGC N/A
- 52 Week Low
- GXAI $1.00
- FLGC $7.37
- 52 Week High
- GXAI $7.50
- FLGC $81.90
- Technical
- Relative Strength Index (RSI)
- GXAI 34.66
- FLGC 27.29
- Support Level
- GXAI $1.45
- FLGC $8.73
- Resistance Level
- GXAI $1.54
- FLGC $10.25
- Average True Range (ATR)
- GXAI 0.12
- FLGC 1.47
- MACD
- GXAI -0.04
- FLGC -0.39
- Stochastic Oscillator
- GXAI 21.12
- FLGC 6.12
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.